{
    "2014-07-29": [
        "MRK and PFE have very different views on inverting",
        "Your estimate for MRK Q2 2014 has been scored",
        "MRK posts Q2 eps of 85 cents vs 81 cent estimate",
        "Merck & Co., Inc. MRK Tops Q2 EPS by 5c",
        "R&D costs going up at MRK in H2 - Thats a win for Perlmutter. Focus is on R&D progress, not failure",
        "Merck beats forecasts, newer drugs offset impact of generics"
    ]
}